EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating Interleukin-6, Tumour Necrosis Factor Alpha, and Myeloperoxidase as Biomarkers in Severe Osteoarthritis Patients: A Biostatistical Perspective

Laura Jane Coleman, John L. Byrne, Stuart Edwards, Rosemary O’Hara

LabMed · 2025

DOI: 10.3390/labmed2020008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift LabMed, 2025. Verfasst von Laura Jane Coleman und 3 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: President’s Research Fellowship Scholarship at South East Technological University Carlow.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study employed advanced biostatistical methods to investigate Interleukin-6 (IL-6), Tumour Necrosis Factor Alpha (TNF-α), and Myeloperoxidase (MPO) levels in serum and plasma samples from patients with severe osteoarthritis (OA) compared to volunteers. The primary aim was to evaluate the diagnostic potential of these biomarkers and address statistical challenges, including non-normal data distribution and non-aged-matched groups.

Design

Using Enzyme-Linked Immunosorbent Assays (ELISAs), IL-6, TNF-α, and MPO concentrations were analysed in 58 OA patients and 28 volunteers. Statistical analyses included Shapiro–Wilk tests to assess normality, a Mann–Whitney U (MWU) test to compare biomarker levels, and sensitivity analyses using Rank-based ANCOVA, and regression models were used to address non-normal data distributions and to validate the findings under adjustments for age and gender. Levene’s test was used to evaluate the homogeneity of variables.

Results

Serum TNF-α and plasma MPO were significantly higher in OA patients than in volunteers (p < 0.05), while IL-6 levels were non-significant (p = 0.160). MWU tests confirmed significant differences for TNF-α (p = 0.045) and MPO (p = 0.0001). Sensitivity analysis using Rank-based ANCOVA and regression models confirmed the robustness of these biomarkers, with TNF-α (p = 0.037) and MPO (p = 0.0099) retaining statistical significance after adjusting for covariates. IL-6 remained non-significant across all analyses.

Conclusions

TNF-α and MPO emerged as statistically robust biomarkers for severe OA, with the serum samples better reflecting inflammation than plasma. These findings underscore the importance of using advanced biostatistical methods such as Rank-based ANCOVA and regression to validate biomarkers, particularly in heterogenous datasets. Future research should incorporate larger, more diverse cohorts and detailed demographic profiling to explore the early diagnostic potential of these biomarkers and further understand OA progression.

Förderung

  • President’s Research Fellowship Scholarship at South East Technological University Carlow

Zitieren

APA

Coleman, L. J., Byrne, J. L., Edwards, S., & O’Hara, R. (2025). Evaluating Interleukin-6, Tumour Necrosis Factor Alpha, and Myeloperoxidase as Biomarkers in Severe Osteoarthritis Patients: A Biostatistical Perspective. LabMed. https://doi.org/10.3390/labmed2020008

Vancouver

Coleman LJ, Byrne JL, Edwards S, O’Hara R. Evaluating Interleukin-6, Tumour Necrosis Factor Alpha, and Myeloperoxidase as Biomarkers in Severe Osteoarthritis Patients: A Biostatistical Perspective. LabMed. 2025. doi:10.3390/labmed2020008

BibTeX
@article{Coleman2025,
  author = {Coleman, Laura Jane and Byrne, John L. and Edwards, Stuart and O’Hara, Rosemary},
  title = {Evaluating Interleukin-6, Tumour Necrosis Factor Alpha, and Myeloperoxidase as Biomarkers in Severe Osteoarthritis Patients: A Biostatistical Perspective},
  journal = {LabMed},
  year = {2025},
  doi = {10.3390/labmed2020008}
}
Kostenlos starten →